GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a generic caused cancer have won a supreme court ruling in Canada, after also chalking up wins in the ...

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

The findings mirror those from GSK’s previously reported DREAMM-7 study, which pitted Blenrep against Johnson & Johnson’s Darzalex. That trial yielded a 36.6-month median PFS for Blenrep ...

However, months later GSK renewed its bid to market the drug, and the EMA accepted its marketing authorization application in July 2024. GSK wins EU backing for multiple myeloma drug, Blenrep ...

WILMINGTON, N.C., June 18, 2025 /PRNewswire/ -- Catalyst Clinical Research today proudly announces it has won the Excellence in Clinical Trial Management category in the Fierce CRO Awards by ...

Josh Liendo went 21.88 to win the men’s 50 freestyle at the 2025 Bell Canadian Trials Monday night, his time earning him a spot at Worlds.

Litigator of the (Past) Week: A Defense Win for Google in $1.3B Ad Tech Trial 6 minute read June 18, 2025 By Ross Todd ...

Media: Julie Cunningham (617) 519-6264 Marc Boston (215) 429-7034 Investor: Peter Dannenbaum (732) 594-1579 Steven Graziano (732) 594-1583 ...